Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694746 · ClinicalTrials.gov registry record · Phase 1
Study of Fish Oil to Reduce ALT Levels in Adolescents
A Phase 1 study, sponsored by Boston University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00694746: Clinical Trial Phase 1 study, sponsored by Boston University.
NCT00694746 is a Phase 1 study that was terminated before completion, run by Boston University. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00694746, a Phase 1 study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.
Interventions
- DRUG Placebo
- DRUG Omega-3-acid ethyl esters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Why NCT00694746 stopped before completion
NCT00694746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00694746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00694746 about?
NCT00694746 is a clinical study titled "Study of Fish Oil to Reduce ALT Levels in Adolescents". This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.
What is the current status of trial NCT00694746?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-06. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00694746?
The interventions under investigation include: Placebo (DRUG), Omega-3-acid ethyl esters (DRUG).
Who is sponsoring clinical trial NCT00694746?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00694746's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia